Robert W. Weaver, MD
Hematology/oncology in Brandon, FL
About Dr. Robert Weaver
Dr. Robert Weaver is a physician specializing in hematology/oncology practicing in Brandon, FL, a graduate of University of South Florida College of Medicine (2000). Records list 2 practice addresses. Affiliated with Adventhealth Tampa, Adventhealth Wesley Chapel, St Josephs Hospital and 1 more. Treated 757 Medicare patients in 2024.
| Specialty | Hematology/oncologyOther hematology/oncology doctors in Brandon |
|---|---|
| Credentials | MD |
| Education | University of South Florida College of Medicine, 2000CMS Doctors and Clinicians |
| Gender | Male |
| NPI number | 1578543799National Provider Identifier (CMS NPPES), issued January 2006 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
| Telehealth | Offers telehealth servicesCMS Doctors and Clinicians |
Where Dr. Robert Weaver practices
- Florida Cancer Specialists & Research Institute, LLC 403 S Kings Ave, 100 Florida Cancer Specialists Pl, Brandon, FL 33511 (813) 982-3460 · Directions · group of 496 clinicians
- Florida Cancer Specialists & Research Institute, LLC 3000 Medical Park Dr, Suite 250, Tampa, FL 33613 (813) 632-6220 · Directions · group of 496 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Dr. Robert Weaver's specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Medical Oncology Primary | FL ME87855 |
| Hematology | FL ME87855 |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Hospital affiliations of Dr. Robert Weaver
- Adventhealth TampaHospital · Tampa, FL
- Adventhealth Wesley ChapelHospital · Wesley Chapel, FL
- St Josephs HospitalHospital · Tampa, FL
- Tampa General HospitalHospital · Tampa, FL
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Dr. Robert Weaver's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,309 | $7.61 |
| Insertion of needle into vein for collection of blood sample | 1,289 | $8.65 |
| Injection of drug or substance under skin or into muscle | 820 | $13.71 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 593 | $124.20 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 472 | $16.07 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 304 | $88.13 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 218 | $58.80 |
| Injection of additional new drug or substance into vein | 203 | $14.49 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Dr. Robert Weaver's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.
Payments from drug and device companies to Dr. Robert Weaver (2025)
$5,678.18 in 182 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 182 | $5,678.18 |
Paying companies: AstraZeneca Pharmaceuticals LP ($524.88), Daiichi Sankyo Inc. ($482.25), Gilead Sciences, Inc. ($448.70), TerSera Therapeutics LLC ($356.95), Pfizer Inc. ($355.73), Celgene Corporation ($312.17).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Robert Weaver
What kind of clinician is Dr. Robert Weaver?
Dr. Robert Weaver is listed as a physician specializing in hematology/oncology.
Where does Dr. Robert Weaver practice?
Florida Cancer Specialists & Research Institute, LLC at 403 S Kings Ave, 100 Florida Cancer Specialists Pl, Brandon, FL 33511, and 1 other address in the records.
What is the office phone number for Dr. Robert Weaver?
The listed office number is (813) 982-3460. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Robert Weaver?
The National Provider Identifier is 1578543799.
Does Dr. Robert Weaver accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Dr. Robert Weaver affiliated with?
Adventhealth Tampa, Adventhealth Wesley Chapel, St Josephs Hospital, Tampa General Hospital.
Where did Dr. Robert Weaver go to medical school?
University of South Florida College of Medicine, graduating in 2000.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2026-07-17 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.